Multiple sclerosis: interferon-beta induces CD123+BDCA2− dendritic cells that produce IL-6 and IL-10 and have no enhanced type I interferon production
- 1 January 2005
- journal article
- clinical trial
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 158 (1-2) , 204-212
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Mouse and human dendritic cell subtypesNature Reviews Immunology, 2002
- Interferons α and β as Immune Regulators—A New LookImmunity, 2001
- Dendritic cells derived from patients with multiple sclerosis show high CD1a and low CD86 expressionMultiple Sclerosis Journal, 2001
- Interferon β in multiple sclerosis: is IL-12 suppression the key?Immunology Today, 2000
- Reciprocal Control of T Helper Cell and Dendritic Cell DifferentiationScience, 1999
- The Enigmatic Plasmacytoid T Cells Develop into Dendritic Cells with Interleukin (IL)-3 and CD40-LigandJournal of Experimental Medicine, 1997
- Dendritic Cells Enhance Growth and Differentiation of CD40-activated B LymphocytesJournal of Experimental Medicine, 1997
- The Cell Surface Phenotype of Human Natural Interferon‐α Producing Cells as Determined by Flow CytometryScandinavian Journal of Immunology, 1996
- The Dendritic Cell System and its Role in ImmunogenicityAnnual Review of Immunology, 1991
- Rating neurologic impairment in multiple sclerosisNeurology, 1983